Search Results

There are 32851 results for: content related to: The Efficacy and Tolerability of Nebivolol in Hypertensive African American Patients

  1. You have free access to this content
    Investigation of the different adrenoceptor targets of nebivolol enantiomers in rat thoracic aorta

    British Journal of Pharmacology

    Volume 156, Issue 4, February 2009, Pages: 601–608, T Tran Quang, B Rozec, L Audigane and C Gauthier

    Version of Record online : 4 FEB 2009, DOI: 10.1111/j.1476-5381.2009.00074.x

  2. Effects of Commonly Administered Agents and Genetics on Nebivolol Pharmacokinetics: Drug-Drug Interaction Studies

    The Journal of Clinical Pharmacology

    Volume 51, Issue 4, April 2011, Pages: 575–585, Dr Charles Lindamood, Dr Stephan Ortiz, Dr Andrew Shaw, Dr Russ Rackley and Dr J. Christopher Gorski

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270010370846

  3. Nebivolol: Pharmacologic Profile of an Ultraselective, Vasodilatory β1-Blocker

    The Journal of Clinical Pharmacology

    Volume 48, Issue 2, February 2008, Pages: 225–239, L. Michael Prisant

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270007310378

  4. You have free access to this content
    Different Pharmacological Properties of Two Enantiomers in a Unique β-Blocker, Nebivolol

    Cardiovascular Therapeutics

    Volume 26, Issue 2, Summer 2008, Pages: 115–134, Louis J. Ignarro

    Version of Record online : 28 JUN 2008, DOI: 10.1111/j.1527-3466.2008.00044.x

  5. You have free access to this content
    Pharmacological Mechanisms of Clinically Favorable Properties of a Selective β1-Adrenoceptor Antagonist, Nebivolol

    Cardiovascular Drug Reviews

    Volume 22, Issue 3, September 2004, Pages: 155–168, Alexey Kuroedov, Francesco Cosentino and Thomas F. Lüscher

    Version of Record online : 7 JUN 2006, DOI: 10.1111/j.1527-3466.2004.tb00138.x

  6. You have free access to this content
    A Randomized, Double-Blind, Placebo-Controlled Parallel-Group Study to Assess the Efficacy and Safety of Nebivolol, a Novel β-Blocker, in Patients With Mild to Moderate Hypertension

    The Journal of Clinical Hypertension

    Volume 9, Issue 9, September 2007, Pages: 667–676, Robert J. Weiss, Michael A. Weber, Albert A. Carr and Will A. Sullivan

    Version of Record online : 5 SEP 2007, DOI: 10.1111/j.1524-6175.2007.06679.x

  7. You have free access to this content
    Nebivolol: A Highly Selective β1-Adrenergic Receptor Blocker That Causes Vasodilation by Increasing Nitric Oxide

    Cardiovascular Therapeutics

    Volume 26, Issue 3, Fall 2008, Pages: 189–202, Sandeep Gupta and Harold M. Wright

    Version of Record online : 13 AUG 2008, DOI: 10.1111/j.1755-5922.2008.00054.x

  8. Nebivolol Dilates Human Penile Arteries and Reverses Erectile Dysfunction in Diabetic Rats through Enhancement of Nitric Oxide Signaling

    The Journal of Sexual Medicine

    Volume 7, Issue 8, August 2010, Pages: 2681–2697, Javier Angulo, Harold M. Wright, Pedro Cuevas, Rocío González-Corrochano, Argentina Fernández, Begoña Cuevas, José M. La Fuente, Sandeep Gupta and Iñigo Sáenz de Tejada

    Version of Record online : 26 FEB 2010, DOI: 10.1111/j.1743-6109.2010.01710.x

  9. You have free access to this content
    Effect of nebivolol on renal nitric oxide availability and tubular function in patients with essential hypertension

    British Journal of Clinical Pharmacology

    Volume 80, Issue 3, September 2015, Pages: 425–435, Frank H. Mose, Janni M. Jensen, Safa Therwani, Jesper Mortensen, Annebirthe B. Hansen, Jesper N. Bech and Erling B. Pedersen

    Version of Record online : 5 JUN 2015, DOI: 10.1111/bcp.12627

  10. A pharmacokinetic drug interaction study between nebivolol and paroxetine in healthy volunteers

    Journal of Clinical Pharmacy and Therapeutics

    Volume 39, Issue 5, October 2014, Pages: 535–540, C. Briciu, M. Neag, D. Muntean, L. Vlase, C. Bocsan, A. Buzoianu, A.-M. Gheldiu, M. Achim and A. Popa

    Version of Record online : 21 MAY 2014, DOI: 10.1111/jcpt.12180

  11. You have free access to this content
    Nebivolol Efficacy and Safety in Patients with Stage I-II Hypertension

    Clinical Cardiology

    Volume 33, Issue 4, April 2010, Pages: E20–E27, Mark Greathouse

    Version of Record online : 16 FEB 2010, DOI: 10.1002/clc.20508

  12. Nebivolol Potentiates the Efficacy of PDE5 Inhibitors to Relax Corpus Cavernosum and Penile Arteries from Diabetic Patients by Enhancing the NO/cGMP Pathway

    The Journal of Sexual Medicine

    Volume 11, Issue 5, May 2014, Pages: 1182–1192, Juan I. Martínez-Salamanca, José M. La Fuente, José Cardoso, Argentina Fernández, Pedro Cuevas, Harold M. Wright and Javier Angulo

    Version of Record online : 20 FEB 2014, DOI: 10.1111/jsm.12477

  13. Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signalling

    Liver International

    Volume 33, Issue 4, April 2013, Pages: 561–568, Thomas Reiberger, Berit Anna Payer, Philipp Schwabl, Hubert Hayden, Thomas Horvatits, Bernhard Jäger, Thomas Hummel, Markus Mitterhauser, Michael Trauner, Valentin Fuhrmann, Bernhard Angermayr, Markus Peck-Radosavljevic and Vienna Hepatic Hemodynamic Lab

    Version of Record online : 20 JAN 2013, DOI: 10.1111/liv.12101

  14. Pharmacokinetics of nebivolol in the rat: low oral absorption, loss in the gut and systemic stereoselectivity

    Biopharmaceutics & Drug Disposition

    Volume 34, Issue 6, September 2013, Pages: 312–320, Forugh Sanaee, Daniel Valente Neves, Vera Lucia Lanchote and Fakhreddin Jamali

    Version of Record online : 15 JUN 2013, DOI: 10.1002/bdd.1847

  15. You have free access to this content
    Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study

    European Journal of Heart Failure

    Volume 14, Issue 2, February 2012, Pages: 219–225, Viviane M. Conraads, Marco Metra, Otto Kamp, Gilles W. De Keulenaer, Burkert Pieske, José Zamorano, Panos E. Vardas, Michael Böhm and Livio Dei Cas

    Version of Record online : 18 FEB 2014, DOI: 10.1093/eurjhf/hfr161

  16. Stereochemical comparison of nebivolol with other β-blockers

    Chirality

    Volume 20, Issue 2, February 2008, Pages: 103–109, Carsten D. Siebert, André Hänsicke and Thomas Nagel

    Version of Record online : 10 DEC 2007, DOI: 10.1002/chir.20509

  17. Cardiovascular Effects of Intracerebroventricular Injections of (±)-Nebivolol and its Enantiomers—a Comparison with those of Metoprolol in the Rat

    Journal of Pharmacy and Pharmacology

    Volume 43, Issue 7, July 1991, Pages: 504–509, M. MIDOL-MONNET, M. DAVY, M. HEIMBURGER, F. BESLOT and Y. COHEN

    Version of Record online : 12 APR 2011, DOI: 10.1111/j.2042-7158.1991.tb03523.x

  18. You have free access to this content
    The vasodilator action of nebivolol in forearm vasculature of subjects with essential hypertension

    British Journal of Clinical Pharmacology

    Volume 48, Issue 3, September 1999, Pages: 460–463, Dawes, Brett, Chowienczyk, Mant and Ritter

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2125.1999.00037.x

  19. You have free access to this content
    Effects of nebivolol on left ventricular function in elderly patients with chronic heart failure: results of the ENECA study

    European Journal of Heart Failure

    Volume 7, Issue 4, June 2005, Pages: 631–639, Istvan Edes, Zbigniew Gasior and Krystian Wita

    Version of Record online : 28 MAY 2005, DOI: 10.1016/j.ejheart.2004.10.015

  20. Beta-blockade with nebivolol enhances the acetylcholine-induced cutaneous vasodilation

    Clinical Pharmacology & Therapeutics

    Volume 69, Issue 4, April 2001, Pages: 238–244, Sandrine Kubli, François Feihl and Bernard Waeber

    Version of Record online : 2 APR 2001, DOI: 10.1067/mcp.2001.114670